Looking through to 2027, UBS upgrades ‘quality compounder’ ASML to buy

Neutral 0.0
UBS analysts recommend investors focus on the 20% eps CAGR ASML is expected to deliver between 2027 and 2030
Read Source Login to use Pulse AI

Pulse AI Analysis

Pulse analysis not available yet. Click "Get Pulse" above.

This analysis was generated using Pulse AI, Glideslope's proprietary AI engine designed to interpret market sentiment and economic signals. Results are for informational purposes only and do not constitute financial advice.